EYPT Similar Chart Price Prediction
The price of EYPT is predicted to go up 1.1%, based on the high correlation periods with FL. The similarity of these two price pattern on the periods is 97.36%.
EYPT
FL
Up: 1.1%Similarity: 97.36%
EYPT Revenue Forecast
EYPT EPS Forecast
EYPT FAQs
What is EYPT revenue forecast for next quarter？
What is EYPT eps forecast for next quarter？
EYPT Analyst's Forecast
Yigal Nochomovitz
Citigroup
Strong Buy
2025-01-07
Price Target
$33
Upside
+257.92%
Citi initiated coverage of EyePoint with a Buy rating and $33 price target. The firm expects both EyePoint and competitor Ocular Therapeutix (OCUL) to capture meaningful share in wet age-related macular degeneration, but also expects one player to eventually dominate. Citi's real-time field checks suggest efficacy data "skew strongly" to EyePoint. It believes the company can conservatively take 40% peak share in wet AMD, which should drive a multi-billion U.S. opportunity.
Greg Harrison
Scotiabank
Buy
2024-10-16
Price Target
$18
Upside
+59.57%
